Direct medical cost of managing IBD patients: A Canadian population-based study

Inflammatory Bowel Diseases

Volumn 18, Issue 8, 2012, Pages 1498-1508

  Bernstein, Charles N ^a   Longobardi, Teresa ^a,b   Finlayson, Greg ^c   Blanchard, James F ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Canada, ulcerative colitis; Crohn's disease; medical cost; population based study

Indexed keywords

INFLIXIMAB;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; COST OF ILLNESS; CROHN DISEASE; DRUG COST; ENTERITIS; FEMALE; HEALTH CARE COST; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MANITOBA; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84863983658     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21878     Document Type: Article

References (19)

1. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006; 101: 1559-1568.
2. The burden of inflammatory bowel disease in Canada. A report of the Crohn's and Colitis Foundation of Canada.
3. Longobardi T, Bernstein CN,. Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis. Am J Gastroenterol. 2007; 102: 1683-1691.
4. Silverstein MD, Loftus EV Jr, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999; 117: 49-57.
5. Duricova D, Pedersen N, Elkjaer M, et al. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis. 2010; 16: 347-353.
6. Assasi N, Blackhouse, G, Xie F, et al. Anti-TNF-α drugs for refractory inflammatory bowel disease: clinical- and cost-effectiveness analyses. CADTH. 2009; 120: 1-72.
7. Roos LL, Mustard CA, Nicol JP,. Registries and administrative data: organization and accuracy. Med Care. 1993; 31: 201-212.
8. Roos LL, Nicol JP,. A research registry: uses, development, and accuracy. J Clin Epidemiol. 1999; 52: 39-47.
9. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's Disease and Ulcerative Colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149: 916-924.
10. Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000; 95: 1955-1960.
11. Rubenstein JH, Chong RY, Cohen RD,. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol. 2002; 35: 151-156.
12. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008; 135: 1907-1913.
13. Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004; 53: 1471-1478.
14. Ebinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German university hospital. Gastroenterol Hepatol. 2004; 19: 192-199.
15. Odes S, Vardi H, Friger M, et al. European Collaborative Study on Inflammatory Bowel Disease. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology. 2006; 131: 719-728.
16. Saro C, de la Coba C, Casado MA, et al. Resource use in patients with Crohn's disease treated with infliximab. Aliment Pharmacol Ther. 2007; 26: 1313-1323
17. Nugent Z, Blanchard JF, Bernstein CN,. A population-based study of health-care resource use among infliximab users. Am J Gastroenterol. 2010; 105: 2009-2016.
18. Nguyen G, Shaw S, Nugent Z, et al. Outcomes of patients with Crohn's disease have improved from 1998 to 2008 and are associated with increased specialist care. Gastroenterology. 2011; 141: 90-97.
19. Targownik LE, Nugent Z, Bernstein CN,. The risk of early and late colectomy in patients with ulcerative colitis: results from a population-based cohort. Gastroenterology. 2011; 141 (abstract).